HomeInsightsStock Comparison

Ipca Laboratories Ltd vs Zydus Lifesciences Ltd Stock Comparison

Ipca Laboratories Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Jul 17, 2025

Key Highlights

  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1471 as of 17 Jul 13:10.
  • The P/E Ratio of Ipca Laboratories Ltd changed from 28.9 on March 2020 to 51.6 on March 2025 . This represents a CAGR of 10.14% over 6 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Ipca Laboratories Ltd changed from ₹ 17538 crore on March 2020 to ₹ 38088 crore on March 2025 . This represents a CAGR of 13.80% over 6 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Ipca Laboratories Ltd for the Mar '25 is ₹ 2272 crore as compare to the Dec '24 revenue of ₹ 2265 crore. This represent the growth of 0.31% The revenue of Zydus Lifesciences Ltd for the Mar '25 is ₹ 6608 crore as compare to the Dec '24 revenue of ₹ 5326 crore. This represent the growth of 24.07%.
  • The ebitda of Ipca Laboratories Ltd for the Mar '25 is ₹ 249.63 crore as compare to the Dec '24 ebitda of ₹ 483.19 crore. This represent the decline of -48.34% The ebitda of Zydus Lifesciences Ltd for the Mar '25 is ₹ 1986 crore as compare to the Dec '24 ebitda of ₹ 1444 crore. This represent the growth of 37.49%.
  • The net profit of Ipca Laboratories Ltd changed from ₹ 166.21 crore to ₹ 65.78 crore over 8 quarters. This represents a CAGR of -37.09% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1248 crore over 8 quarters. This represents a CAGR of 5.97% .
  • The Dividend Payout of Ipca Laboratories Ltd changed from 9.68 % on March 2020 to 15.59 % on March 2025 . This represents a CAGR of 8.27% over 6 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories Ltd soars 1.02%, rises for third straight session

Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs ...

Read more

15 Jul 2025 13:05

News

Ipca Laboratories to hold AGM

Ipca Laboratories announced that the 75th Annual General Meeting(AGM) of the company will ...

Read more

11 Jul 2025 17:40

News

Ipca Laboratories Ltd spurts 0.19%, up for five straight sessions

Ipca Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs ...

Read more

08 Jul 2025 13:00

News

Ipca Laboratories Ltd soars 1.25%, Gains for third straight session

Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at...

Read more

12 Jun 2025 13:05

News

Board of Ipca Laboratories recommends final dividend

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held...

Read more

29 May 2025 14:29

News

Ipca Laboratories to announce Quarterly Result

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

15 May 2025 15:38

Zydus Lifesciences Ltd News Hub

News

Zydus' Matoda facility completes Remote Regulatory Assessment of USFDA

Zydus Lifesciences announced that the USFDA conducted a Remote Regulatory Assessment (RRA)...

Read more

16 Jul 2025 17:55

News

Zydus Lifesciences gets USFDA Nod for Celecoxib Capsules

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones ...

Read more

15 Jul 2025 15:45

News

Zydus Life Matoda facility receives two observations from USFDA after inspection

In a regulatory filing, the company confirmed that the USFDA conducted a follow-up inspect...

Read more

19 Jun 2025 09:50

News

Zydus Lifesciences appoints Managing Director

Zydus Lifesciences has approved the appointment of s. Swati Dalal as the Additional Direct...

Read more

16 Jun 2025 14:16

News

Zydus Life subsidiary ZHL appoints Swati Dalal as MD

The appointment was approved by the nomination and remuneration committee (NRC). Swati Dal...

Read more

16 Jun 2025 14:42

News

Zydus Life receives USFDA EIR for Gujarat facility

The inspection was conducted by the USFDA from March 10 to March 14, 2025. Following the r...

Read more

12 Jun 2025 09:55

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ipca Laboratories Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Ipca Laboratories Ltd or Zydus Lifesciences Ltd?

Market cap of Ipca Laboratories Ltd is 37,082 Cr while Market cap of Zydus Lifesciences Ltd is 97,463 Cr

What are the key factors driving the stock performance of Ipca Laboratories Ltd and Zydus Lifesciences Ltd?

The stock performance of Ipca Laboratories Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ipca Laboratories Ltd and Zydus Lifesciences Ltd?

As of July 17, 2025, the Ipca Laboratories Ltd stock price is INR ₹1461.65. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹968.6.

How do dividend payouts of Ipca Laboratories Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Ipca Laboratories Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions